FDA recommends concentrated Kratom be scheduled as illicit substance
UNITED STATES, JUL 29 – FDA urges classifying synthetic 7-hydroxymitragynine as Schedule I to curb opioid-like abuse while maintaining legal access to natural kratom used by over 24 million Americans.
- On July 29, 2025, U.S. health officials proposed adding 7-hydroxymitragynine , a compound found in kratom, to the list of Schedule I controlled substances.
- This action responds to rising concerns about synthetic 7-OH products that mimic opioids and pose health risks, unlike largely unregulated natural kratom.
- The FDA previously sent warning letters on July 15, 2025, to seven companies marketing concentrated 7-OH in tablets, gummies, and drinks, stating these products may be dangerous.
- FDA Commissioner Marty Makary emphasized that the focus is on the synthetic opioid derivative 7-hydroxymitragynine because of its addictive qualities, rather than on the natural kratom leaf or its ground form.
- The scheduling is intended to protect consumers from harmful synthetic products while preserving safe access to natural kratom used regularly by over 24 million Americans.
83 Articles
83 Articles
US health officials warn about kratom-linked products
WASHINGTON — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban.
FDA pushes for ban of potent Kratom derivative 7-OH amid safety concerns
A new opioid threat you probably haven't heard about is targeting kids. Products containing 7-OH are currently being sold legally in the form of items such as gummy bears and ice cream at smoke shops across the Valley.
Trump FDA Pushes For ‘Gas Station’ Opioid To Be Added To DEA’s Drug Schedule List
by Emily Kopp at CDN - WASHINGTON — The Food and Drug Administration (FDA) formally requested for a popular kratom derivative to be classified as a controlled substance Tuesday. The Trump administration’s top health officials said at a press conference Tuesday that they are seeking to curb the use of 7-hydroxymitragynine, or 7-OH. Kratom derives from a tropical evergreen tree that … Click to read the rest HERE-> Trump FDA Pushes For ‘Gas Station…
Coverage Details
Bias Distribution
- 54% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium